ARQT FY 2025 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$376M+91.3% YoY

Gross Profit

$339M90.2% margin

Operating Income

-$12M-3.3% margin

Net Income

-$16M-4.3% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$433M

Total Liabilities

$243M

Stockholders' Equity

$189M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$376M	$197M	+91.3%
Gross Profit	$339M	$177M	+91.3%
Operating Income	-$12M	-$128M	+90.5%
Net Income	-$16M	-$140M	+88.5%